Who, St. Jude triggers a revolutionary international delivery of childhood cancer medicines

World Health Organization (WHO) and Children's Research Hospital St. Judas started distributing critically needed drugs for cancer in 2 of 6 pilots, by Global platform for access to childhood cancer drugs. Currently, these drugs are delivered to Mongolia and Uzbekistan, and the following shipments planned for Ecuador, Jordan, Nepal and Zambia. The treatments are expected to reach approximately 5,000 children with cancer in at least 30 hospitals in these countries within this year.

The global platform is the first such initiative. Pilot countries will receive a continuous supply of childhood cancer drugs, at no costs. In countries with low and medium income (LMIC), childhood cancer rates are often below 30%, much lower than those in high -income countries. Six additional countries have been officially invited to join the platform.

The initiative is ready to become the greatest, with the aim of reaching 50 nations in the next 5 to 7 years. It aims to eventually provide medication to treat approximately 120,000 children with cancer in LMIC, significantly reducing the mortality rate.

“For too long, children with cancer lacked access to life saving life,” said Dr. Tedros Adhana Ghebreyesus, who is the CEO. “This unique partnership between WHO and St. Jude works to provide cancer medicines that ensures the quality of pediatric hospitals in low and medium -income countries. Who is proud to be part of this joint initiative with St. Jude, bringing health and hope to children around the world. “

Each year, 400,000 children around the world develop cancer. Most of these children, who live in restricted resources, are unable to consistently obtain or afford cancer medicines. It is estimated that 70% of children from these settings die from cancer due to factors such as lack of appropriate treatment, treatment disorders, or poor quality drugs.

“The chances of survival of cancer are largely determined by where they were born, which makes this one of the most important inequality in global health care,” said James R. Downing, MD, President and Executive Director of St. Jude. “St. Jude is based on the dream of Danny Thomas that no child should die at the dawn of life. Developing this platform, we believe that this dream can one day be achieved for children encouraged by cancer, no matter where they live. “

St. Judas and who announced the 2021 platform to ensure that children around the world have access to rescue treatments. The platform brings together government, pharmaceutical industry and non -governmental organizations in a unique model of cooperation aimed at creating a solution for children with cancer. Access to Ko-Dizajna deals with the wider needs of national stakeholders, with an emphasis on the construction of capacity and long-term sustainability.

The platform provides comprehensive support for the end to the end, from consolidation of global demand to market design, helping countries in choosing medicine and development of treatment standards. It is a transformative model for a wider global health community that together works to resolve health challenges, especially for children and unprotected diseases. To achieve this, St. Jude and which partner with the UNICEF Supply Department and the Pan American Health Organisal (Paho) ​​Pan American Strategic Fund.

Notes editors:

World Health Organization

Dedicated by the well -being of all people and science guided by science, the World Health Organization (WHO) leads and advocates global efforts to give everyone, everywhere, a chance in a safe and healthy life. Who is the UN Health Agency that connects nations, partners and people on the first lines at 150+ locations – which leads to the world to emergency in health, preventing the disease, solving the fundamental causes of health problems and expanding access to medicines and health care. Who is the mission to promote health, protect the world and serve vulnerable.

About childhood cancer, which cooperates with over 100 global partners through Global Interest Cancer InitiativeIn order to support governments in the development of high quality cancer centers and regional satellites that provide wound, accurate diagnosis and effective treatments for children with cancer. Which also develops standards and tools for conducting planning and implementation of interventions for diagnosis, treatment and palliative and survivors. Progress on childhood cancer, as well as other non-compliant diseases, are part of the Fourth UN General Assembly of the UN General Assembly on Uncomfortable Diseases held in September 2025.

Children's Research Hospital St. Jude

The Children's Research Hospital of St. Judas leads the way the world understands, heals and cures childhood cancer, sickness disease and other life -threatening disorders. It is a non-profit organization based in Memphis, Tennessee, USA, and the only national comprehensive cancer center, which was dedicated only to children. Treatments developed in St. Judeu helped stimulate the total childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Judas shares the breakthroughs that he does to help doctors and researchers at local hospitals and cancer centers around the world to improve the quality of treatment and care for even more children. To find out more, visit ostae.org,read Progress: Digital magazine and follow St. Jude on social networks on@stjuderesearch .

Who and St. Jude first collaborated in 2018, when St. Jude became the first to collaborate a childhood cancer and committed $ 15 million to create Global Interest Cancer Initiative (Global initiative). This initiative supports more than 70 governments under the construction and maintenance of local cancer programs and aims to increase survival to 60% by 2030. Global platform for access to childhood cancer drugs (Global Platform) synergates with a global initiative, and activities that are conducted by this new effort is expected to contribute significantly to achieve the goals of the initiative. The global platform is part Strategic Plan of St. JudeFocused on accelerating progress on catastrophic disease in childhood globally through the greatest investment of institutions in research and care for patients.